Literature DB >> 11179302

Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.

J K McCormick1, A A Pragman, J C Stolpa, D Y Leung, P M Schlievert.   

Abstract

Streptococcal toxic shock syndrome (STSS) is a highly lethal, acute-onset illness that is a subset of invasive streptococcal disease. The majority of clinical STSS cases have been associated with the pyrogenic toxin superantigens (PTSAgs) streptococcal pyrogenic exotoxin A or C (SPE A or C), although cases have been reported that are not associated with either of these exotoxins. Recent genome sequencing projects have revealed a number of open reading frames that potentially encode proteins with similarity to SPEs A and C and to other PTSAgs. Here, we describe the cloning, expression, purification, and functional characterization of a novel exotoxin termed streptococcal pyrogenic exotoxin J (SPE J). Purified recombinant SPE J (rSPE J) expressed from Escherichia coli stimulated the expansion of both rabbit splenocytes and human peripheral blood lymphocytes, preferentially expanded human T cells displaying Vbeta2, -3, -12, -14, and -17 on their T-cell receptors, and was active at concentrations as low as 5 x 10(-6) microg/ml. Furthermore, rSPE J induced fevers in rabbits and was lethal in two models of STSS. Biochemically, SPE J had a predicted molecular weight of 24,444 and an isoelectric point of 7.7 and lacked the ability to form the cystine loop structure characteristic of many PTSAgs. SPE J shared 19.6, 47.1, 38.8, 18.1, 19.6, and 24.4% identity with SPEs A, C, G, and H, streptococcal superantigen, and streptococcal mitogenic exotoxin Z-2, respectively, and was immunologically cross-reactive with SPE C. The characterization of a seventh functional streptococcal PTSAg raises important questions relating to the evolution of the streptococcal superantigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179302      PMCID: PMC98031          DOI: 10.1128/IAI.69.3.1381-1388.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Nucleotide sequence of streptococcal pyrogenic exotoxin type C.

Authors:  S C Goshorn; P M Schlievert
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

2.  Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease.

Authors:  T F Kagawa; J C Cooney; H M Baker; S McSweeney; M Liu; S Gubba; J M Musser; E N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B.

Authors:  L P Johnson; J J L'Italien; P M Schlievert
Journal:  Mol Gen Genet       Date:  1986-05

4.  Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994.

Authors:  P Descheemaeker; F VAN Loock; M Hauchecorne; P Vandamme; H Goossens
Journal:  J Med Microbiol       Date:  2000-05       Impact factor: 2.472

Review 5.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

6.  Bacteriophage association of streptococcal pyrogenic exotoxin type C.

Authors:  S C Goshorn; P M Schlievert
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

7.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

10.  The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation.

Authors:  T Proft; S L Moffatt; K D Weller; A Paterson; D Martin; J D Fraser
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  14 in total

1.  Peptide antagonists of superantigen toxins.

Authors:  Raymond Kaempfer
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

2.  Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.

Authors:  Kim Ekelund; Jessica Darenberg; Anna Norrby-Teglund; Steen Hoffmann; Didi Bang; Peter Skinhøj; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.

Authors:  Kim Ekelund; Peter Skinhøj; Jesper Madsen; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 4.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.

Authors:  Laura M Smoot; John K McCormick; James C Smoot; Nancy P Hoe; Ian Strickland; Robert L Cole; Kent D Barbian; Cathleen A Earhart; Douglas H Ohlendorf; L George Veasy; Harry R Hill; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan.

Authors:  Tadayoshi Ikebe; Akihito Wada; Yoshishige Inagaki; Kumiko Sugama; Rieko Suzuki; Daisuke Tanaka; Aki Tamaru; Yoshihiro Fujinaga; Yoshiaki Abe; Yoshikata Shimizu; Haruo Watanabe
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.

Authors:  Romain Paillot; Carl Robinson; Karen Steward; Nicola Wright; Thibaud Jourdan; Nicola Butcher; Zoe Heather; Andrew S Waller
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

8.  Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.

Authors:  Hong-Zhou Lu; Xin-Hua Weng; Bai Zhu; Haijing Li; You-Kuan Yin; Yong-Xin Zhang; David W Haas; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 9.  Diagnostic role of tests for T cell receptor (TCR) genes.

Authors:  E Hodges; M T Krishna; C Pickard; J L Smith
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

10.  Genetic analysis of group A streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China.

Authors:  Ming-huan Zheng; Zhen-quan Jiao; Li-jie Zhang; Sang-jie Yu; Guang-peng Tang; Xiao-mei Yan; Li-hua He; Fan-liang Meng; Fei Zhao; Mao-jun Zhang; Di Xiao; Yong-hong Yang; Wei Nie; Jian-zhong Zhang; Zi-jun Wang
Journal:  J Clin Microbiol       Date:  2008-12-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.